Fairchem Organics Limited submitted a transcript of its Q1 FY2027 earnings conference call held on July 28, 2026, pursuant to SEBI (LODR) Regulations, 2015 Regulation 30 read with Schedule III - Part A, Para A - Clause 15(b).

Financial Performance Q1 FY27

  • Revenue from operations: ₹176 crores, representing a 34.4% year-on-year increase compared to Q1 FY26
  • EBITDA: ₹18 crores with EBITDA margin of 10.14%
  • Net profit: ₹10 crores
  • Raw material processed: 12,400 tonnes
  • Products sold: 13,500 tonnes

Revenue Mix Breakdown

  • Dimer acid: 30% of revenue
  • Linoleic acid: 42% of revenue
  • Isostearic acid: 4% of revenue
  • Other by-products: 24% of revenue

Operational Highlights

Current capacity utilization stands at approximately 60%. The company targets increasing utilization to 70-75% by the end of FY27, aiming for 5-7% quarterly growth in quantity. Revenue growth was primarily driven by higher price realization due to elevated raw material costs and reduced imports amid supply chain constraints.

Strategic Initiatives and Cost Optimization

  • Energy conservation efforts reduced power consumption by over 30% and solid fuel consumption by over 35%
  • Continuous time and motion studies to optimize manpower
  • Catalyst and consumable optimization programs underway
  • 7-8 major customers are seeking supply chain diversification, presenting new opportunities

Product Development and Innovation

  • Isostearic acid production using green process technology (only third manufacturer globally)
  • Bypass fat plant commissioned
  • New oleochemical product to be introduced in Q2 FY27
  • R&D expenditure: Approximately ₹50 lakhs annually (1-1.5% of sales)

Market Environment and Outlook

  • Reduced Chinese dumping and Middle East crisis-related supply constraints improved pricing environment
  • India-UK Free Trade Agreement and expected India-EU FTA expected to boost export competitiveness
  • Recent rupee depreciation supports export growth
  • Current export contribution: 7-8% of revenue, primarily dimer and Isostearic acids
  • 40% of revenue comes from paint industry, with no plans to reduce this dependence

Capacity Expansion

  • Current total capacity: 80,000 metric tons
  • Additional 40,000 metric tons capacity planned for new oleochemical product
  • Trial runs for new capacity to begin in Q2 FY27

Isostearic Acid Development

  • Facing stringent entry barriers in cosmetics industry (primary application)
  • Approval process with major customers ongoing, with some at advanced stages (steps 4-5 of 5)
  • Expected to reach over 80% capacity utilization in 1-2 years
  • Manufacturing process provides competitive advantage through integrated plant and green technology

Raw Material Sourcing

  • 100% domestic raw material sourcing
  • Inverted duty structure challenge: 22.5% duty on raw materials vs. 7.5% duty on finished products

Price Realization Trends

  • Q1 FY27 realizations increased by approximately 25% from Q4 FY26
  • Q1 FY27 realizations increased by approximately 30% from Q1 FY26

Management Outlook

Management expressed cautious optimism for FY27, expecting to maintain current revenue and margin run rates. The company focuses on increasing capacity utilization rather than capacity expansion, with no debt plans despite improved conditions.